Immutep Limited (IMMP) DCF Valuation
- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
Immutep Limited (IMMP) Bundle
Simplify Immutep Limited (IMMP) valuation with this customizable DCF Calculator! Featuring real Immutep Limited (IMMP) financials and adjustable forecast inputs, you can test scenarios and uncover Immutep Limited (IMMP) fair value in minutes.
Discounted Cash Flow (DCF) - (USD MM)
Year | AY1 2020 |
AY2 2021 |
AY3 2022 |
AY4 2023 |
AY5 2024 |
FY1 2025 |
FY2 2026 |
FY3 2027 |
FY4 2028 |
FY5 2029 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | 4.7 | 2.5 | .1 | 2.2 | 2.4 | 2.2 | 2.0 | 1.8 | 1.7 | 1.6 |
Revenue Growth, % | 0 | -47 | -95.71 | 1957.72 | 9.59 | -8.28 | -8.28 | -8.28 | -8.28 | -8.28 |
EBITDA | -8.4 | -11.1 | -19.8 | -24.6 | -27.7 | -2.2 | -2.0 | -1.8 | -1.7 | -1.6 |
EBITDA, % | -179.76 | -447.75 | -18708.86 | -1128.79 | -1159.44 | -100 | -100 | -100 | -100 | -100 |
Depreciation | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.2 | 1.1 | 1.0 | .9 |
Depreciation, % | 27.78 | 52.17 | 1211.18 | 58.81 | 52.4 | 58.23 | 58.23 | 58.23 | 58.23 | 58.23 |
EBIT | -9.7 | -12.3 | -21.1 | -25.9 | -29.0 | -2.2 | -2.0 | -1.8 | -1.7 | -1.6 |
EBIT, % | -207.54 | -499.92 | -19920.04 | -1187.6 | -1211.84 | -100 | -100 | -100 | -100 | -100 |
Total Cash | 16.4 | 37.4 | 49.8 | 76.8 | 113.1 | 2.2 | 2.0 | 1.8 | 1.7 | 1.6 |
Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Account Receivables | 2.1 | 3.8 | 5.2 | 5.0 | 4.7 | 2.0 | 1.8 | 1.6 | 1.5 | 1.4 |
Account Receivables, % | 45.3 | 154.34 | 4915.01 | 227.43 | 196.74 | 89.06 | 89.06 | 89.06 | 89.06 | 89.06 |
Inventories | .0 | -3.5 | -.7 | .0 | .0 | -.9 | -.8 | -.7 | -.7 | -.6 |
Inventories, % | 0.000013357477 | -142.62 | -650.54 | 0.000057049589 | 0 | -40 | -40 | -40 | -40 | -40 |
Accounts Payable | 1.0 | 1.1 | 1.8 | 3.4 | 2.4 | 1.6 | 1.5 | 1.4 | 1.2 | 1.1 |
Accounts Payable, % | 21.9 | 45.99 | 1682.32 | 155.41 | 98.66 | 73.31 | 73.31 | 73.31 | 73.31 | 73.31 |
Capital Expenditure | .0 | .0 | .0 | .0 | -.6 | -.2 | -.2 | -.1 | -.1 | -.1 |
Capital Expenditure, % | -0.25844 | -0.39316 | -13.45 | -1.34 | -24.27 | -7.94 | -7.94 | -7.94 | -7.94 | -7.94 |
Tax Rate, % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
EBITAT | -9.7 | -12.3 | -21.1 | -25.9 | -29.0 | -2.2 | -2.0 | -1.8 | -1.7 | -1.6 |
Depreciation | ||||||||||
Changes in Account Receivables | ||||||||||
Changes in Inventories | ||||||||||
Changes in Accounts Payable | ||||||||||
Capital Expenditure | ||||||||||
UFCF | -9.5 | -9.1 | -23.4 | -23.5 | -29.1 | 1.8 | -1.0 | -1.0 | -.9 | -.8 |
WACC, % | 13.51 | 13.51 | 13.51 | 13.51 | 13.51 | 13.51 | 13.51 | 13.51 | 13.51 | 13.51 |
PV UFCF | ||||||||||
SUM PV UFCF | -.8 | |||||||||
Long Term Growth Rate, % | 2.00 | |||||||||
Free cash flow (T + 1) | -1 | |||||||||
Terminal Value | -7 | |||||||||
Present Terminal Value | -4 | |||||||||
Enterprise Value | -5 | |||||||||
Net Debt | -100 | |||||||||
Equity Value | 95 | |||||||||
Diluted Shares Outstanding, MM | 1,201 | |||||||||
Equity Value Per Share | 0.08 |
What You Will Receive
- Comprehensive Financial Model: Immutep Limited’s actual data facilitates accurate DCF valuation.
- Complete Forecast Control: Modify revenue growth, margins, WACC, and other essential drivers.
- Real-Time Calculations: Automatic updates provide immediate results as adjustments are made.
- Professional-Grade Template: A polished Excel file crafted for high-quality valuation.
- Flexible and Reusable: Designed for adaptability, enabling repeated use for in-depth forecasts.
Key Features
- Customizable Clinical Parameters: Adjust essential inputs such as trial timelines, patient demographics, and treatment efficacy.
- Instant DCF Valuation: Quickly calculates intrinsic value, NPV, and additional metrics with ease.
- High-Precision Accuracy: Leverages Immutep Limited’s (IMMP) actual financial data for credible valuation results.
- Simplified Scenario Analysis: Evaluate various assumptions and effortlessly compare results.
- Efficiency Booster: Avoid the hassle of constructing intricate valuation models from the ground up.
How It Works
- Download the Template: Gain immediate access to the Excel-based IMMP DCF Calculator.
- Input Your Assumptions: Modify the yellow-highlighted cells for growth rates, WACC, margins, and other parameters.
- Instant Calculations: The model automatically recalculates Immutep Limited’s intrinsic value.
- Test Scenarios: Experiment with various assumptions to assess potential changes in valuation.
- Analyze and Decide: Leverage the results to inform your investment or financial decisions.
Why Choose This Calculator for Immutep Limited (IMMP)?
- User-Friendly Interface: Perfectly crafted for both novices and seasoned users.
- Customizable Parameters: Adjust inputs effortlessly to suit your financial analysis.
- Real-Time Feedback: Monitor immediate changes to Immutep's valuation as you tweak variables.
- Pre-Configured Data: Comes loaded with Immutep's latest financial information for swift evaluations.
- Relied Upon by Experts: Favored by investors and analysts for making data-driven choices.
Who Should Use This Product?
- Finance Students: Discover valuation techniques and apply them using real-time data for Immutep Limited (IMMP).
- Academics: Integrate professional models into your coursework or research focused on Immutep Limited (IMMP).
- Investors: Evaluate your own assumptions and analyze valuation scenarios for Immutep Limited (IMMP).
- Analysts: Enhance your workflow with a pre-built, customizable DCF model tailored for Immutep Limited (IMMP).
- Small Business Owners: Understand how large public companies like Immutep Limited (IMMP) are assessed in the market.
What the Template Contains
- Pre-Filled Data: Includes Immutep Limited’s historical financials and forecasts.
- Discounted Cash Flow Model: Editable DCF valuation model with automatic calculations.
- Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on custom inputs.
- Key Financial Ratios: Analyze Immutep Limited’s profitability, efficiency, and leverage.
- Customizable Inputs: Edit revenue growth, margins, and tax rates with ease.
- Clear Dashboard: Charts and tables summarizing key valuation results.